CDKN1A and prostate adenocarcinoma: These in vitro data were supported by the TCGA-PRAD cohort, where T2E+ PCa tissue specimens exhibited significantly decreased CDKN1A and HES6 expression levels compared to T2E-PCa, while HDAC1 and KDM1A were increased (Figure 7E).